Insulet (PODD)

• Market cap: $10.4B
• 1 day: 0.36%
• 5 days: 5.8%
• 1 month: 12.54%
• 3 months: -9.21%
• 6 months: -20.45%
• Year to date: -47.05%
• 1 year: -54.02%
• 5 years: -49.95%
• 10 years: 304.1%
• Sector: Healthcare
• Industry: Medical Devices

About: Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Employees: 5,400